174 related articles for article (PubMed ID: 8298143)
1. Discrepancy between IIA phenotype and IIB genotype in a patient with a variant of von Willebrand disease.
Ribba AS; Christophe O; Derlon A; Cherel G; Siguret V; Lavergne JM; Girma JP; Meyer D; Pietu G
Blood; 1994 Feb; 83(3):833-41. PubMed ID: 8298143
[TBL] [Abstract][Full Text] [Related]
2. Characterization of recombinant von Willebrand factor corresponding to mutations in type IIA and type IIB von Willebrand disease.
Ribba AS; Voorberg J; Meyer D; Pannekoek H; Pietu G
J Biol Chem; 1992 Nov; 267(32):23209-15. PubMed ID: 1429668
[TBL] [Abstract][Full Text] [Related]
3. Influence of mutations and size of multimers in type II von Willebrand disease upon the function of von Willebrand factor.
Christophe O; Ribba AS; Baruch D; Obert B; Rouault C; Niinomi K; Piétu G; Meyer D; Girma JP
Blood; 1994 Jun; 83(12):3553-61. PubMed ID: 8204881
[TBL] [Abstract][Full Text] [Related]
4. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
[TBL] [Abstract][Full Text] [Related]
5. Type IIB mutation His-505-->Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib.
Rabinowitz I; Randi AM; Shindler KS; Tuley EA; Rustagi PK; Sadler JE
J Biol Chem; 1993 Sep; 268(27):20497-501. PubMed ID: 8376405
[TBL] [Abstract][Full Text] [Related]
6. Recombinant von Willebrand factor Arg578-->Gln. A type IIB von Willebrand disease mutation affects binding to glycoprotein Ib but not to collagen or heparin.
Randi AM; Jorieux S; Tuley EA; Mazurier C; Sadler JE
J Biol Chem; 1992 Oct; 267(29):21187-92. PubMed ID: 1400429
[TBL] [Abstract][Full Text] [Related]
7. Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor.
Inbal A; Kornbrot N; Harrison P; Randi AM; Sadler JE
Thromb Haemost; 1993 Dec; 70(6):1058-62. PubMed ID: 8165601
[TBL] [Abstract][Full Text] [Related]
8. The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor.
Ribba AN; Hilbert L; Lavergne JM; Fressinaud E; Boyer-Neumann C; Ternisien C; Juhan-Vague I; Goudemand J; Girma J; Mazurier C; Meyer D
Blood; 2001 Feb; 97(4):952-9. PubMed ID: 11159522
[TBL] [Abstract][Full Text] [Related]
9. Molecular study of von Willebrand disease: identification of potential mutations in patients with type IIA and type IIB.
Piétu G; Ribba AS; de Paillette L; Chérel G; Lavergne JM; Bahnak BR; Meyer D
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):415-21. PubMed ID: 1420817
[TBL] [Abstract][Full Text] [Related]
10. Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor.
Hilbert L; Jenkins PV; Gaucher C; Meriane E; Collins PW; Pasi KJ; Mazurier C
Thromb Haemost; 2000 Aug; 84(2):188-94. PubMed ID: 10959688
[TBL] [Abstract][Full Text] [Related]
11. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM
J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830
[TBL] [Abstract][Full Text] [Related]
12. Defects in type IIA von Willebrand disease: a cysteine 509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein Ib-IX.
Lavergne JM; De Paillette L; Bahnak BR; Ribba AS; Fressinaud E; Meyer D; Pietu G
Br J Haematol; 1992 Sep; 82(1):66-72. PubMed ID: 1419804
[TBL] [Abstract][Full Text] [Related]
13. Type 2M:Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets.
Mancuso DJ; Kroner PA; Christopherson PA; Vokac EA; Gill JC; Montgomery RR
Blood; 1996 Oct; 88(7):2559-68. PubMed ID: 8839848
[TBL] [Abstract][Full Text] [Related]
14. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
15. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.
Rabinowitz I; Tuley EA; Mancuso DJ; Randi AM; Firkin BG; Howard MA; Sadler JE
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9846-9. PubMed ID: 1409710
[TBL] [Abstract][Full Text] [Related]
17. Leu 697-->Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease.
Hilbert L; Gaucher C; de Romeuf C; Horellou MH; Vink T; Mazurier C
Blood; 1994 Mar; 83(6):1542-50. PubMed ID: 8123843
[TBL] [Abstract][Full Text] [Related]
18. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
Weiss HJ; Sussman II
Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
[TBL] [Abstract][Full Text] [Related]
19. Duplication of a methionine within the glycoprotein Ib binding domain of von Willebrand factor detected by denaturing gradient gel electrophoresis in a patient with type IIB von Willebrand disease.
Ribba AS; Lavergne JM; Bahnak BR; Derlon A; Piétu G; Meyer D
Blood; 1991 Oct; 78(7):1738-43. PubMed ID: 1912563
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of type 2b von Willebrand disease mutations: implications for the mechanism of von Willebrand factor binding to platelets.
Cooney KA; Ginsburg D
Blood; 1996 Mar; 87(6):2322-8. PubMed ID: 8630394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
